Total Payments
$8,212
2024 Payments
$2,442
Companies
35
Transactions
372
Medicare Patients
1,488
Medicare Billing
$185,997
Payment Breakdown by Category
Food & Beverage$8,156 (99.3%)
Education$55.68 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,156 | 369 | 99.3% |
| Education | $55.68 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,292 | 62 | $0 (2024) |
| Novo Nordisk Inc | $1,151 | 54 | $0 (2024) |
| Lilly USA, LLC | $985.33 | 45 | $0 (2024) |
| ABBVIE INC. | $685.21 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $668.73 | 29 | $0 (2024) |
| PFIZER INC. | $383.62 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $303.04 | 13 | $0 (2024) |
| Astellas Pharma US Inc | $291.06 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $244.40 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $232.41 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,442 | 105 | AstraZeneca Pharmaceuticals LP ($499.77) |
| 2023 | $2,547 | 116 | Novo Nordisk Inc ($536.16) |
| 2022 | $1,856 | 86 | AstraZeneca Pharmaceuticals LP ($325.09) |
| 2021 | $1,186 | 55 | AbbVie Inc. ($181.81) |
| 2020 | $44.85 | 2 | Avanir Pharmaceuticals, Inc. ($25.04) |
| 2019 | $50.54 | 2 | PFIZER INC. ($50.54) |
| 2018 | $28.67 | 2 | PFIZER INC. ($28.67) |
| 2017 | $56.84 | 4 | PFIZER INC. ($56.84) |
All Payment Transactions
372 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: VACCINES | ||||||
| 12/13/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Biological | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Neuropsychiatry | ||||||
| 10/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: UROLOGY | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Hematology | ||||||
| 09/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.66 | General |
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Biological | ||||||
| 09/05/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $25.18 | General |
| Category: Cardiovascular | ||||||
| 09/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.07 | General |
| 08/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Obesity | ||||||
| 08/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Biological | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 497 | 691 | $217,084 | $69,146 |
| 2022 | 13 | 476 | 706 | $160,531 | $57,953 |
| 2021 | 13 | 359 | 500 | $96,199 | $38,624 |
| 2020 | 4 | 156 | 242 | $58,135 | $20,274 |
Total Patients
1,488
Total Services
2,139
Medicare Billing
$185,997
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 74 | 123 | $52,770 | $16,249 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 124 | $38,062 | $12,280 | 32.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 63 | 63 | $20,733 | $8,421 | 40.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 34 | 89 | $26,584 | $7,773 | 29.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 48 | 50 | $18,874 | $5,534 | 29.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 60 | 60 | $12,676 | $4,907 | 38.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 19 | 37 | $11,125 | $3,273 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 45 | $9,676 | $3,222 | 33.3% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 15 | 19 | $8,641 | $2,415 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $8,610 | $2,325 | 27.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 20 | 21 | $6,693 | $2,319 | 34.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 39 | 39 | $2,640 | $427.06 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 124 | $27,876 | $11,966 | 42.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 42 | 97 | $24,602 | $7,420 | 30.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 51 | $15,504 | $6,849 | 44.2% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 61 | 62 | $21,368 | $6,832 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $10,175 | $5,182 | 50.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 39 | 79 | $14,304 | $4,108 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 57 | $9,266 | $3,846 | 41.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 16 | 46 | $13,054 | $3,493 | 26.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 40 | 40 | $7,600 | $3,397 | 44.7% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Facility | 2022 | 20 | 20 | $4,367 | $1,520 | 34.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 13 | 25 | $5,350 | $1,432 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,740 | $1,185 | 31.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $605.00 | $351.67 | 58.1% |
About Dr. Eric Lao, MD
Dr. Eric Lao, MD is a Internal Medicine healthcare provider based in South Windsor, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801878681.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Lao, MD has received a total of $8,212 in payments from pharmaceutical and medical device companies, with $2,442 received in 2024. These payments were reported across 372 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($8,156).
As a Medicare-enrolled provider, Lao has provided services to 1,488 Medicare beneficiaries, totaling 2,139 services with total Medicare billing of $185,997. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location South Windsor, CT
- Active Since 11/16/2005
- Last Updated 06/22/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1801878681
Products in Payments
- BREZTRI (Drug) $751.45
- MOUNJARO (Drug) $582.04
- VRAYLAR (Drug) $569.82
- TRELEGY ELLIPTA (Drug) $501.66
- Ozempic (Drug) $435.47
- Rybelsus (Drug) $398.97
- ELIQUIS (Drug) $310.38
- BEVESPI AEROSPHERE (Drug) $238.40
- JARDIANCE (Drug) $229.34
- XIFAXAN (Drug) $216.69
- Veozah (Drug) $214.72
- TRULICITY (Drug) $206.65
- REXULTI (Drug) $188.35
- ENTRESTO (Drug) $181.35
- Cologuard Collection Kit (Device) $174.54
- AIRSUPRA (Drug) $157.72
- SHINGRIX (Biological) $148.56
- SOLIQUA 100/33 (Biological) $135.44
- UBRELVY (Drug) $135.20
- GEMTESA (Drug) $130.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in South Windsor
Dr. Marcy Qureshi, D.o, D.O
Internal Medicine — Payments: $15,235
Internal Medicine $15,235
Satyarani Tallapureddy, M.d, M.D
Internal Medicine — Payments: $11,634
Internal Medicine $11,634
Anupma Saini, Md, MD
Internal Medicine — Payments: $2,189
Internal Medicine $2,189
Pooja Narwal, M.d, M.D
Internal Medicine — Payments: $2,058
Internal Medicine $2,058
Ameena Madan Paramasivan, M.d.,, M.D.,
Internal Medicine — Payments: $1,003
Internal Medicine $1,003
Michael Martin, Md, MD
Internal Medicine — Payments: $487.02
Internal Medicine $487.02